Top Growth Trends in the Blood Stream Infection Testing Market: Insights into Market Size and Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers Contributing to the Growth and Expansion of the Blood Stream Infection Testing Market?
The anticipated advancement of the blood stream infection testing market is being fueled by the escalating prevalence of infectious diseases. Infectious diseases, described as ailments triggered by pathogenic microbes such as bacteria, viruses, fungi, or parasites, are seeing an uptick due to factors such as greater global travel, urbanization, climate change, antibiotic resistance, and gaps in vaccination coverage. It’s crucial to perform blood stream infection tests in cases of infectious diseases for the detection and identification of sepsis-causing pathogens and other serious infections, facilitating effective and targeted treatment. To illustrate, the World Health Organization’s (WHO) – a United Nations agency based in Switzerland – latest World Malaria report in December 2023 indicated malaria cases rose to 249 million in 2022, an increase from 244 million in the previous year. The estimated malaria deaths in 2022 were 608,000 as against 610,000 in 2021. Thus, the surging prevalence of infectious diseases underlines the escalating demand within the blood stream infection testing market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20514&type=smp
#How Will the CAGR of the Blood Stream Infection Testing Market Influence Its Overall Growth by 2034?
In recent times, there has been a notable expansion in the market size of blood stream infection testing. The market is predicted to escalate from a valuation of $7.59 billion in 2024 to a substantial value of $8.49 billion in 2025, advancing at a compound annual growth rate (CAGR) of 11.9%. Factors such as an upswing in hospital-acquired infections, a growing problem of antimicrobial resistance, a rise in the aging population, higher healthcare spending, and a growing rate of chronic diseases are contributors to the growth observed in the historic period.
Projections show a swift expansion for the blood stream infection testing market in the coming years, reaching a value of $13.19 billion by 2029, with an 11.7% compound annual growth rate (CAGR). Reasons for the growth during this period are linked to an increased need for fast diagnostic tests, wider use of molecular diagnostics, increased emphasis on personalized medicine, governmental efforts to control infections, and an increase in multi-drug-resistant pathogens. The forecast period sees major trends such as a rising use of AI in diagnostic tools, the fusion of telemedicine and diagnostic services, increased demand for home-based testing kits, the creation of multiplex diagnostic platforms, and expanding collaborations between diagnostic companies and hospitals.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20514
What New Market Trends Are Reshaping theBlood Stream Infection Testing Market and Its Opportunities?
Leading firms in the bloodstream infection testing market are concentrating on creating innovative goods such as blood testing cartridges to maintain their market presence. Blood testing cartridges, which are single-use devices utilized for blood sample analysis in diagnostic tests, come equipped with preloaded reagents, integrated sensors, or microfluidic channels that allow the identification of specific biomarkers, pathogens, or conditions from a small blood sample. For example, in August 2022, Immunexpress Pty Ltd., a molecular diagnostics company based in Australia, introduced SeptiCyte RAPID cartridges. These cartridges use undiluted ethylenediaminetetraacetic acid (EDTA) blood as an approved sample type, proven to correlate highly with other blood collection techniques through a multi-site European study. This progress enhances the precision and effectiveness of sepsis diagnosis, facilitating broader and faster clinical implementation, possibly revolutionizing patient care and reducing healthcare expenses.
Who Are the Leading Market Players Fueling Growth in the Blood Stream Infection Testing Market Trend?
Major companies operating in the blood stream infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthcare Private Limited, Becton Dickinson and Company (BD), Grifols S.A., Hologic Inc., BIOMÉRIEUX SA, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., DiaSorin S.p.A., Seegene Inc., Cepheid, Meridian Bioscience Inc., Biocartis NV, T2 Biosystems Inc., Molzym GmbH & Co. KG, Curetis GmbH, Accelerate Diagnostics Inc., OpGen Inc.
Order Your Report Now For A Swift Delivery:
How is the Global Blood Stream Infection Testing Market Segemented?
The blood stream infection testing market covered in this report is segmented –
1) By Product Type: Instruments, Reagents And Consumables, Software And Services
2) By Sample Type: Whole Blood, Blood Culture
3) By Technology: Polymerase Chain Reaction (PCR), Mass Spectroscopy, In Situ Hybridization, Other Technologies
4) By End-User: Hospitals And Diagnostic Centers, Laboratory Service Providers, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Instruments: Blood Culture Systems, Automated Microbial Identification Systems, Molecular Diagnostic Instruments
2) By Reagents and Consumables: Blood Culture Media, Antimicrobial Susceptibility Testing Reagents, Nucleic Acid Extraction Kits
3) By Software and Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20514&type=smp
Which Geographics are Influencing the Growth of the Blood Stream Infection Testing Market?
North America was the largest region in the blood stream infection testing market in 2024. The regions covered in the blood stream infection testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Blood Stream Infection Testing Market 2025, By The Business Research Company:
Infection Control Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report
Infection Control Supplies Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/infection-control-supplies-global-market-report
Urinary Tract Infection Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
